Traveling with Cannabis in the Schengen Area: Rules and Risks

Traveling with cannabis across borders within the Schengen Area presents a complex legal landscape that catches many travelers off guard. Despite the absence of routine border checks between Schengen member states, cannabis remains a controlled substance under the 1961 UN Single Convention on Narcotic Drugs, and each EU country maintains its own national drug laws. A product that is legal to possess in the Netherlands or Germany may result in criminal prosecution in France, Sweden, or Hungary. For medical cannabis patients, the Schengen Certificate (formally known as the Article 75 certificate under the Schengen Convention) provides a legal pathway for carrying prescribed controlled substances across Schengen borders. This certificate, issued by the competent authority of the patient's home country, permits travel with up to 30 days' supply of a prescribed narcotic medication. However, the practical application of this system to cannabis is inconsistent — not all countries accept cannabis under the certificate framework, and even with valid documentation, travelers may face delays, confiscation, or legal complications at border crossings, airports, and train stations.

The Schengen Certificate system was designed to enable patients who depend on controlled substance medications to travel within the Schengen Area without facing criminal penalties. For cannabis patients, the process begins with obtaining a certificate from the competent health authority in their country of residence — in Germany this is the Bundesopiumstelle (Federal Opium Agency), in the Netherlands the CIBG, and in Italy the Ministry of Health. The certificate must specify the patient's name, the prescribing physician, the medication (including the international non-proprietary name where applicable), the daily dosage, and the duration of travel. It must be stamped and signed by the issuing authority and is valid for a maximum of 30 days of travel. The certificate must be presented to authorities upon request and should be carried alongside the original prescription and the medication in its original pharmacy packaging with intact labels.

Despite the formal framework, practical challenges abound when traveling with medical cannabis in the Schengen Area. Not all member states fully recognize cannabis as a legitimate medication eligible for the Schengen Certificate — some countries' competent authorities may refuse to issue certificates for cannabis, while destination countries may not accept cannabis-specific certificates from other member states. Border police and airport security personnel may not be familiar with the Schengen Certificate for cannabis, leading to prolonged detention and questioning even when documentation is in order. Air travel adds another layer of complexity: while Schengen flights are technically domestic from an immigration perspective, airline policies on carrying cannabis may be more restrictive than national laws. Some airports have explicit policies on cannabis transport, while others defer to airline discretion. Patients are strongly advised to research the specific laws and practical enforcement environment of both their departure and destination countries before traveling.

Recreational cannabis travelers face far greater legal risk. Even in countries that have decriminalized personal possession — such as the Netherlands, Portugal, Spain, and parts of Germany — transporting cannabis across national borders remains a criminal offense under international law. The absence of border checks within the Schengen Area does not eliminate the risk: police can conduct random checks on trains, buses, and highways within border zones, and drug-detection programs at airports and train stations operate independently of immigration controls. The penalties for cross-border cannabis transport vary enormously — from a fine or caution in some countries to significant prison sentences in others. France, Sweden, and most Eastern European member states maintain strict enforcement policies that can result in criminal records and travel bans for cannabis transport offenses.

Germany's 2024 cannabis reform, which legalized personal possession of up to 25 grams for adults, has added new complexity to the Schengen transport landscape. German law explicitly prohibits importing cannabis from abroad, even from countries where it is also legal. The Netherlands' longstanding tolerance policy (gedoogbeleid) permits purchase from licensed coffee shops but does not extend to export. Luxembourg's home cultivation provisions similarly do not authorize taking homegrown cannabis across borders. Travelers should understand that domestic legalization in one country creates absolutely no right to transport cannabis to or through another country. The legal principle of territorial sovereignty means each country's drug laws apply independently within its borders, and the EU has no competence to override national criminal law in this area.